by Alison Bass | Mar 20, 2009 | Uncategorized
At a talk I gave Wednesday at George Washington University, someone in the audience asked why there seemed to be an inordinate number of psychiatrists on the take to the drug industry. Was it something about the specialty of psychiatry itself or the individuals...
by Alison Bass | Mar 13, 2009 | Uncategorized
The news that a Massachusetts anesthesiologist fabricated data in at least 21 studies (and probably more) is disturbing on several counts. First, it raises serious questions about the credibility of the peer review process at all the supposedly respectable journals...
by Alison Bass | Mar 6, 2009 | Uncategorized
Not a week goes by without news of the growing concern — among consumer advocates, medical students and Congressional watchdogs — about the financial conflicts of interest that bind doctors to the pharmaceutical industry and may bias their judgment about...
by Alison Bass | Feb 26, 2009 | Uncategorized
The New York Times today reported that the Justice Department has sued Forest Labs for defrauding the government of millions of dollars by illegally marketing Celexa and Lexapro, its two blockbuster antidepressants. The fraud complaint is based on allegations that...
by Alison Bass | Feb 19, 2009 | Uncategorized
In a long-overdue step toward health care reform, the massive economic stimulus bill that the Obama administration approved on Tuesday includes $1.1 billion to compare the effectiveness of drugs, medical devices, surgery and other medical procedures. The money will...
